Association Between Diabetes Management Behaviors and State-Level Social Vulnerability: A Cross-sectional Study.

IF 3.8 3区 医学 Q2 Medicine
Debra Winberg, Nicolas Marchi, Tiange Tang, Lizheng Shi
{"title":"Association Between Diabetes Management Behaviors and State-Level Social Vulnerability: A Cross-sectional Study.","authors":"Debra Winberg, Nicolas Marchi, Tiange Tang, Lizheng Shi","doi":"10.1007/s13300-025-01754-3","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Type 2 diabetes mellitus remains a major public health concern in the United States. Previous research demonstrates that social determinants of health, including inequities in living conditions, directly affect the biological and behavioral outcomes associated with diabetes control and prevention. New tools such as the social vulnerability index (SVI) can be used to assess these inequities. This paper aims to assess the impact of state-level social vulnerability on diabetes management behaviors.</p><p><strong>Methods: </strong>We used data from the Centers for Disease Control/Agency for Toxic Substances and Disease Registry's Social Vulnerability Index (SVI) and the Behavioral Risk Factor Surveillance System (BRFFS) Survey. The final sample included data from 2016 to 2021 and 89,643 people diagnosed with type 2 diabetes. We averaged the SVI and its component indices for each state and categorized them into terciles. The outcome measures included whether the respondents received diabetes education, conducted self-monitoring of blood glucose levels, and received medical care for diabetes. We ran logistic regressions to test the impact of the SVI on the outcomes, adjusting for state and fixed time-fixed effects and covariates. We weighted according to BRFFS guidelines.</p><p><strong>Results: </strong>Individuals in states with moderate social vulnerability were 1.87 times more likely to receive diabetes education than those in states with the lowest vulnerability (p < 0.01). Conversely, those in states with the highest vulnerability were 1.48 times more likely to see a doctor for diabetes care than those in the least vulnerable states (p =  < 0.01). However, individuals in states with moderate vulnerability are less likely to self-monitor their blood sugar levels (OR = 0.74, p = 0.03).</p><p><strong>Conclusions: </strong>People in states with different levels of social vulnerability exhibit differences in behaviors affecting diabetes management, particularly in activities not captured by standard diabetes quality measures. Differences are more apparent in activities that are not part of diabetes quality measures.</p>","PeriodicalId":11192,"journal":{"name":"Diabetes Therapy","volume":" ","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s13300-025-01754-3","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Type 2 diabetes mellitus remains a major public health concern in the United States. Previous research demonstrates that social determinants of health, including inequities in living conditions, directly affect the biological and behavioral outcomes associated with diabetes control and prevention. New tools such as the social vulnerability index (SVI) can be used to assess these inequities. This paper aims to assess the impact of state-level social vulnerability on diabetes management behaviors.

Methods: We used data from the Centers for Disease Control/Agency for Toxic Substances and Disease Registry's Social Vulnerability Index (SVI) and the Behavioral Risk Factor Surveillance System (BRFFS) Survey. The final sample included data from 2016 to 2021 and 89,643 people diagnosed with type 2 diabetes. We averaged the SVI and its component indices for each state and categorized them into terciles. The outcome measures included whether the respondents received diabetes education, conducted self-monitoring of blood glucose levels, and received medical care for diabetes. We ran logistic regressions to test the impact of the SVI on the outcomes, adjusting for state and fixed time-fixed effects and covariates. We weighted according to BRFFS guidelines.

Results: Individuals in states with moderate social vulnerability were 1.87 times more likely to receive diabetes education than those in states with the lowest vulnerability (p < 0.01). Conversely, those in states with the highest vulnerability were 1.48 times more likely to see a doctor for diabetes care than those in the least vulnerable states (p =  < 0.01). However, individuals in states with moderate vulnerability are less likely to self-monitor their blood sugar levels (OR = 0.74, p = 0.03).

Conclusions: People in states with different levels of social vulnerability exhibit differences in behaviors affecting diabetes management, particularly in activities not captured by standard diabetes quality measures. Differences are more apparent in activities that are not part of diabetes quality measures.

糖尿病管理行为与国家层面社会脆弱性的关系:一项横断面研究。
在美国,2型糖尿病仍然是一个主要的公共卫生问题。先前的研究表明,健康的社会决定因素,包括生活条件的不平等,直接影响与糖尿病控制和预防相关的生物学和行为结果。社会脆弱性指数(SVI)等新工具可用于评估这些不平等。本文旨在评估国家层面的社会脆弱性对糖尿病管理行为的影响。方法:我们使用来自疾病控制中心/有毒物质和疾病登记处的社会脆弱性指数(SVI)和行为风险因素监测系统(BRFFS)调查的数据。最终样本包括2016年至2021年的数据,其中有89643人被诊断患有2型糖尿病。我们对每个州的SVI及其组成指数进行平均,并将其分类为类别。结果测量包括受访者是否接受糖尿病教育,是否进行自我血糖水平监测,是否接受糖尿病医疗护理。我们运行逻辑回归来检验SVI对结果的影响,调整状态和固定时间固定效应和协变量。我们根据BRFFS指南进行加权。结果:中等社会脆弱性州的个体接受糖尿病教育的可能性是最低社会脆弱性州的个体的1.87倍(p结论:不同社会脆弱性州的人们在影响糖尿病管理的行为上表现出差异,特别是在标准糖尿病质量测量未捕获的活动中。在不属于糖尿病质量测量的活动中,差异更为明显。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Diabetes Therapy
Diabetes Therapy Medicine-Endocrinology, Diabetes and Metabolism
CiteScore
6.90
自引率
7.90%
发文量
130
审稿时长
6 weeks
期刊介绍: Diabetes Therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions (including devices) across all areas of diabetes. Studies relating to diagnostics and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged. The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Diabetes Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信